Ingalls & Snyder LLC lowered its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 35.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 17,776 shares of the pharmacy operator's stock after selling 9,660 shares during the quarter. Ingalls & Snyder LLC's holdings in CVS Health were worth $798,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently bought and sold shares of CVS. AMF Tjanstepension AB boosted its holdings in shares of CVS Health by 124.1% in the 3rd quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator's stock valued at $3,882,000 after purchasing an additional 34,198 shares during the last quarter. Exchange Traded Concepts LLC boosted its holdings in shares of CVS Health by 61.9% in the 3rd quarter. Exchange Traded Concepts LLC now owns 14,853 shares of the pharmacy operator's stock valued at $934,000 after purchasing an additional 5,679 shares during the last quarter. Procyon Advisors LLC acquired a new position in shares of CVS Health in the 3rd quarter valued at $202,000. Creative Planning boosted its holdings in shares of CVS Health by 23.5% in the 3rd quarter. Creative Planning now owns 250,891 shares of the pharmacy operator's stock valued at $15,776,000 after purchasing an additional 47,737 shares during the last quarter. Finally, Sumitomo Life Insurance Co. boosted its holdings in shares of CVS Health by 3.0% in the 3rd quarter. Sumitomo Life Insurance Co. now owns 17,692 shares of the pharmacy operator's stock valued at $1,112,000 after purchasing an additional 516 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.
CVS Health Price Performance
Shares of CVS stock traded down $0.67 during midday trading on Monday, reaching $65.71. 10,208,186 shares of the company were exchanged, compared to its average volume of 12,149,901. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a market cap of $82.84 billion, a P/E ratio of 16.68, a PEG ratio of 0.60 and a beta of 0.61. The company's 50 day moving average price is $51.11 and its two-hundred day moving average price is $55.99. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.
CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping analysts' consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. On average, sell-side analysts expect that CVS Health Co. will post 5.14 earnings per share for the current year.
CVS Health Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.05%. CVS Health's payout ratio is currently 72.68%.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on the stock. Leerink Partners upgraded shares of CVS Health from a "market perform" rating to an "outperform" rating and lifted their price target for the company from $55.00 to $75.00 in a report on Thursday. TD Cowen lifted their price target on shares of CVS Health from $73.00 to $80.00 and gave the stock a "buy" rating in a research note on Monday, November 25th. Piper Sandler dropped their price target on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research note on Monday, November 25th. Edward Jones raised shares of CVS Health from a "hold" rating to a "buy" rating in a research report on Thursday, January 30th. Finally, Leerink Partnrs raised shares of CVS Health from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, February 12th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, CVS Health presently has an average rating of "Moderate Buy" and a consensus price target of $70.28.
Read Our Latest Research Report on CVS
About CVS Health
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
